Merck Archives - CFO

CFOs On the Move: Week Ending March 26

CFOs On the Move: Week Ending March 26

Condé Nast, Foot Locker, Velocity, Merck, DNA Script, Ibotta, Cano Health, Ring Energy, PG&E, Adobe

By Lauren Muskett | March 26, 2021

CFOs On the Move: Week Ending February 5

CFOs On the Move: Week Ending February 5

Merck, Fetch Rewards, L Brands, Royal Cup Coffee & Tea, The Children’s Place, SMART Global Holdings, RealNetworks, Idea Financial, Virta Health

By Lauren Muskett | February 5, 2021

Merck Drops Out of COVID-19 Vaccine Race

Risk & Compliance

Merck Drops Out of COVID-19 Vaccine Race

Merck's announcement that it is shelving its two vaccine candidates "marks a shocking setback for one of the most storied vaccine makers."

By Matthew Heller | January 25, 2021

Merck Buys OncoImmune in COVID Treatment Move

Merck Buys OncoImmune in COVID Treatment Move

The $425 million deal gives Merck access to a promising therapy for treating seriously ill COVID-19 patients.

By Matthew Heller | November 23, 2020

Merck Enters Race to Develop COVID Vaccine

Merck Enters Race to Develop COVID Vaccine

The world's largest vaccine maker is no longer on the COVID sidelines after acquiring an Austrian biotech and teaming up with a nonprofit.

By Matthew Heller | May 26, 2020

Merck, Sanofi in Deals for Cancer Drug Firms

Merck, Sanofi in Deals for Cancer Drug Firms

The pharma giants each announced they would buy smaller drugmakers to expand cancer-treatment franchises.

By Lauren Muskett | December 9, 2019

Merck Goes Hostile in Versum Takeover Battle

Merck Goes Hostile in Versum Takeover Battle

Versum shareholders are scheduled to vote next month on a merger with Entegris that is valued at less than Merck's $5.9 billion proposal.

By Matthew Heller | March 27, 2019

Bayer to Shed Assets, Cut Jobs Amid Share Pressure

Bayer to Shed Assets, Cut Jobs Amid Share Pressure

It's a broad restructuring of the German conglomerate, which plans to sell its sun-care and foot care businesses and exit its animal health division.

By William Sprouse | November 29, 2018

P&G Buys Merck Unit to Boost OTC Business

P&G Buys Merck Unit to Boost OTC Business

The $4 billion acquisition of Merck's consumer healthcare unit comes amid investor pressure on P&G to increase sales.

By Matthew Heller | April 19, 2018

Data Held Hostage

Risk Management

Data Held Hostage

The damage inflicted in this year’s ransomware attacks will force corporations to review their IT resilience.

By Vincent Ryan | September 28, 2017

Quantifying Cyber Risks

Quantifying Cyber Risks

Companies are clamoring for the data and information they need to manage their exposures.

By David Katz | December 15, 2016

Merck Buys Cough Drug Developer for $1.25B

Merck Buys Cough Drug Developer for $1.25B

The acquisition of Afferent Pharmaceuticals gives Merck access to a drug candidate for treating neurogenic conditions including chronic cough.

By Katie Kuehner-Hebert | June 10, 2016

Ex-Merck Analyst Hit with Insider Trading Rap

Risk & Compliance

Ex-Merck Analyst Hit with Insider Trading Rap

He allegedly helped a friend make more than $700,000 on insider M&A info.

By Matthew Heller | October 15, 2014

CFOs on the Move: Week Ended March 28

CFOs on the Move: Week Ended March 28

Merck, AlixPartners, Laboratory Corp. of America, Catamaran, Bell and Howell, Cyan, RealPage, WPX Energy

By Joan Urdang | March 28, 2014

Transforming Cisco: One Finance Function At a Time

Transforming Cisco: One Finance Function At a Time

Cisco's shares have made a comeback, and CFO Frank Calderoni says a finance unit revamp was one of the key pieces of the company's turnaround.

By Kathy Hoffelder | October 10, 2013